Zevallos-Villegas Annette, Alonso-Moralejo Rodrigo, Cambra Félix, Hermida-Anchuelo Ana, Pérez-González Virginia, Gámez-García Pablo, Sayas-Catalán Javier, De Pablo-Gafas Alicia
Department of Respiratory Medecine, Lung Transplant Unit, "12 de Octubre" University Hospital, "i + 12" Research Institute, Avda de Córdoba s/n, 28041, Madrid, Spain.
Department of General and Digestive Surgery, "12 de Octubre" University Hospital, Madrid, Spain.
J Cardiothorac Surg. 2019 Oct 28;14(1):181. doi: 10.1186/s13019-019-0983-y.
Gastrointestinal complications after lung transplatation are associated with an increased risk of morbidity and mortality. This study aims to describe severe gastrointestinal complications (SGC) after lung transplantation.
We performed a prospective, observational study that included 136 lung transplant patients during a seven year period in a tertiary care universitary hospital. SGC were defined as any diagnosis related to the gastrointestinal or biliary tract leading to lower survival rates or an invasive therapeutic procedure. Early and late complications were defined as those occurring < 30 days and ≥ 30 days post-transplant. The survival function was calculated through the Kaplan-Meier estimator. Variables were analyzed using univariate and multivariate analysis. Statistical significance was defined as p < 0.05.
There were 17 (12.5%) SGC in 17 patients. Five were defined as early. Twelve patients (70.6%) required surgical treatment. Mortality was 52.9% (n = 9). Patients with SGC had a lower overall survival rate compared to those who did not (14 vs 28 months, p = 0.0099). The development of arrhythmias in the first 48 h of transplantation was a risk factor for gastrointestinal complications (p = 0.0326).
SGC are common after lung transplantation and are associated with a considerable increase in morbidity-mortality. Early recognition is necessary to avoid delays in treatment, since a clear predictor has not been found in order to forecast this relevant comorbidity.
肺移植术后的胃肠道并发症与发病率和死亡率的增加相关。本研究旨在描述肺移植术后的严重胃肠道并发症(SGC)。
我们进行了一项前瞻性观察性研究,纳入了一家三级医疗大学医院7年间的136例肺移植患者。SGC被定义为任何与胃肠道或胆道相关的诊断,导致生存率降低或需要进行侵入性治疗。早期和晚期并发症分别定义为移植后<30天和≥30天发生的并发症。通过Kaplan-Meier估计器计算生存函数。使用单变量和多变量分析对变量进行分析。统计学显著性定义为p<0.05。
17例患者发生了17例(12.5%)SGC。5例为早期并发症。12例患者(70.6%)需要手术治疗。死亡率为52.9%(n = 9)。与未发生SGC的患者相比,发生SGC的患者总体生存率较低(14个月对28个月,p = 0.0099)。移植后最初48小时内发生心律失常是胃肠道并发症的一个危险因素(p = 0.0326)。
SGC在肺移植术后很常见,并且与发病率和死亡率的显著增加相关。由于尚未找到明确的预测指标来预测这种相关合并症,因此早期识别对于避免治疗延误是必要的。